Feasibility RCT of definitive chemoradiotherapy or chemotherapy and surgery for oesophageal squamous cell cancer
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The optimal treatment for localised oesophageal squamous cell carcinoma (SCC) is uncertain. We assessed the feasibility of an RCT comparing neoadjuvant treatment and surgery with definitive chemoradiotherapy. METHODS: A feasibility RCT in three centres examined incident patients and reasons for ineligibility using multi-disciplinary team meeting records. Eligible patients were offered participation in the RCT with integrated qualitative research involving audio-recorded recruitment appointments and interviews with patients to inform recruitment training for staff. RESULTS: Of 375 patients with oesophageal SCC, 42 (11.2%) were eligible. Reasons for eligibility varied between centres, with significantly differing proportions of patients excluded because of total tumour length (P=0.002). Analyses of audio-recordings and patient interviews showed that recruiters had challenges articulating the trial design in simple terms, balancing treatment arms and explaining the need for randomisation. Before analyses of the qualitative data and recruiter training no patients were randomised. Following training in one centre 5 of 16 eligible patients were randomised. CONCLUSIONS: An RCT of surgical vs non-surgical treatment for SCC of the oesophagus is not feasible in the UK alone because of the low number of incident eligible patients. A trial comparing diverse treatment approaches may be possible with investment to support the recruitment process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lewin, S., Glenton, C., & Oxman, A. D. (2009) · BMJ · doi:10.1136/bmj.b3496 · Cited by 678
Donovan, J., Little, P., Mills, N., Smith, M., Brindle, L., Jacoby, A., Peters, T., Frankel, S., Neal, D., & Hamdy, F. (2002) · BMJ · doi:10.1136/bmj.325.7367.766 · Cited by 533 · cited 3×
“In the UK, these difficulties were overcome in the ProtecT trial that successfully randomised 1500 men between radical surgery, radiotherapy or active monitoring for localised prostate cancer (Donovan et al, 2002).”
BackgroundSelf-citationDonovan, J. L., Paramasivan, S., de Salis, I., & Toerien, M. (2014) · Trials · doi:10.1186/1745-6215-15-5 · Cited by 262
Self-citation
Cited by
Elliott, D., Husbands, S., Hamdy, F. C., Holmberg, L., & Donovan, J. L. (2017) · European Urology · doi:10.1016/j.eururo.2017.04.036 · Cited by 161
“[24,27,36,44,52,53], and that eligible patients often disliked the concept of randomisation [24,25,27,35,50,52] or had strong treatment preferences for particular interventions [23–25,32,35,44,52,53].”
BackgroundInfluentialRooshenas, L., Elliott, D., Wade, J., Jepson, M., Paramasivan, S., Strong, S., Wilson, C., Beard, D., Blazeby, J. M., Birtle, A., et al. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002147 · Cited by 140
Self-citationDavies, L., Beard, D., Cook, J. A., Price, A., Osbeck, I., & Toye, F. (2021) · Trials · doi:10.1186/s13063-021-05403-5 · Cited by 41
Metadata
- Authors
- Blazeby, J. M., Strong, S., Donovan, J. L., Wilson, C., Hollingworth, W., Crosby, T., Nicklin, J., Falk, S. J., Barham, C. P., Hollowood, A. D., Streets, C. G., Titcomb, D., Krysztopik, R., Griffin, S. M., & Brookes, S. T.
- Venue
- British Journal of Cancer
- Published
- 2014-06-12
- Volume
- 111
- Issue
- 2
- Pages
- 234-240
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2009534579
- Cited by
- 36
- References
- 3
- FWCI
- 3.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.